Position history for B. Metzler seel. Sohn & Co. AG's holdings in ABBOTT LABORATORIES
B. Metzler seel. Sohn & Co. AG holds 1.8M shares of ABT (ABBOTT LABORATORIES), worth $187.3M as of 2026-Q1. The position was increased (+1.0% shares). ABT represents 1.7% of B. Metzler seel. Sohn & Co. AG's portfolio.
Current Value
$187.3M
Current Shares
1.8M
Total Value Change
+$173.8M
Total Shares Change
+1.7M
Other major holders of ABT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 1.8M |
+1.0% |
| $187.3M |
| 1.7% |
| $113.61 |
48 |
| 2025-Q4 | Increased | 1.8M | +3.0% | $226.5M | 2.0% | $125.15 | 50 |
| 2025-Q3 | Increased | 1.8M | +1.6% | $234.9M | 2.1% | $131.85 | 53 |
| 2025-Q2 | Increased | 1.7M | +0.7% | $234.9M | 2.2% | $132.52 | 53 |
| 2025-Q1 | Increased | 1.7M | +87.5% | $227.5M | 2.3% | $128.41 | 82 |
| 2024-Q4 | Increased | 914,635 | +304.7% | $103.4M | 1.1% | $110.14 | 76 |
| 2024-Q3 | Increased | 225,996 | +74.4% | $25.8M | 0.3% | $109.27 | 52 |
| 2024-Q2 | Decreased | 129,575 | -3.5% | $13.5M | 0.1% | $100.45 | 0 |